Literature DB >> 31092159

Cerebral Venous Thrombosis.

Thalia S Field1, Michael D Hill2.   

Abstract

Entities:  

Keywords:  anticoagulants; cerebral venous thrombosis; epidemiology; patient outcome assessment; prognosis; thrombectomy

Year:  2019        PMID： 31092159     DOI： 10.1161/STROKEAHA.119.025334

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

Review 1.  Deep Cerebral Venous Thrombosis Treatment : Endovascular Case using Aspiration and Review of the Various Treatment Modalities.

Authors:  Leonard Ll Yeo; Priscillia Ps Lye; Kong Wan Yee; Yang Cunli; Tu Tian Ming; Andrew Fw Ho; Vijay K Sharma; Bernard Pl Chan; Benjamin Yq Tan; Anil Gopinathan
Journal:  Clin Neuroradiol       Date:  2020-06-11       Impact factor: 3.649

2.  Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States.

Authors:  Fadar Oliver Otite; Smit Patel; Richa Sharma; Pushti Khandwala; Devashish Desai; Julius Gene Latorre; Emmanuel Oladele Akano; Nnabuchi Anikpezie; Saef Izzy; Amer M Malik; Dileep Yavagal; Priyank Khandelwal; Seemant Chaturvedi
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

3.  A Puzzling Diagnosis of Cerebral Vein Thrombosis in a COVID-19-Vaccinated Patient.

Authors:  Isaac Alsallamin; Francisco J Somoza-Cano; Lara Zakarna; Pearl Aggarwal; Rusina Karia; Ameed Bawwab; Deema Chakhachiro; Afnan Alsallamin
Journal:  Cureus       Date:  2022-06-11

4.  Clinical Characteristics, Etiology, Recanalization Rates and Neurological Outcomes in CVT: A Prospective Cohort Study.

Authors:  Rajendra Singh Jain; P V Sripadma; Shankar Tejwani
Journal:  Ann Indian Acad Neurol       Date:  2022-02-08       Impact factor: 1.714

5.  Cerebral venous thrombosis: A typical presentation of COVID-19 in the young.

Authors:  David E Klein; Richard Libman; Claudia Kirsch; Rohan Arora
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-23       Impact factor: 2.136

6.  Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis.

Authors:  Dagmar Krajíčková; Jiří Král; Roman Herzig; Ľudovít Klzo; Antonín Krajina; Jaroslav Havelka; Libor Šimůnek; Oldřich Vyšata; Tran Van Quang; Michal Bar; Martin Vališ
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

7.  Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression.

Authors:  Xiaohui Dong; Xiaohui Liu; Yanqing Liu; Lili Jiang; Huiping Zhang; Bofeng Liu
Journal:  Comput Math Methods Med       Date:  2021-12-31       Impact factor: 2.238

8.  Long-Delayed Manifestation of COVID-19 Coagulopathy Presenting with Severe Cerebral Venous Thrombosis Causes Massive Brain Hemorrhage.

Authors:  Mardjono Tjahjadi; Sinatrya Caropeboka; Christian Permana; Krisandi Susanto; Eka Susanto
Journal:  Asian J Neurosurg       Date:  2022-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.